- Vetter has completed design finalisation, verification studies, and initiated industrialisation for its V-OVS® next closure system, targeting commercial launch in 2027.
- Human Factors and functional studies delivered positive results, supporting usability, safety and manufacturing performance.
Vetter, a Contract Development and Manufacturing Organization (CDMO), has completed several development and verification milestones for V-OVS® next, its updated closure system designed for syringe-based products, as it prepares for commercialisation in 2027.
Developed using market feedback, V-OVS® next features updates focused on handling, functionality and design, with compatibility across a wide range of syringe formats. The system is intended for applications including ophthalmology, aesthetic injectables, diluents and biologics. Following its unveiling at PharmaPack 2025, Vetter has finalised the design and begun industrialisation, including the provision of NFHU materials to primary syringe glass suppliers for further implementation and testing.
As part of the development programme, Vetter completed a second Human Factors study and a key Functional Study, both of which delivered positive results. The second Human Factors study included a use-related risk analysis and confirmed safe and effective handling. Participants comparing V-OVS® next with the original V-OVS® reported improved usability and user experience.
Vetter also assessed the structural performance of V-OVS® next during manufacturing and handling. Initial tests showed improved performance compared with the existing V-OVS®, alongside support for intuitive handling and reduced likelihood of misuse.
“We’ve already had successful conversations with multiple value chain partners and received consistently encouraging responses that reinforce our confidence in this launch.”
Lars Hahn, Senior Vice President Global Sales Organization at Vetter
Vetter stated that it will continue to advance industrialisation activities ahead of the planned 2027 launch, after which both V-OVS® and V-OVS® next will remain available as part of its contract manufacturing portfolio.
